Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

December-10-02

Dow Jones to Cover Contraceptives Under Settlement

Under terms of a settlement reached last Wednesday, Dow Jones & Co., which publishes the Wall Street Journal, will now cover all employee prescription contraceptives approved by the Food and Drug Administration (FDA) as well as “related medical services”. The move comes after three female employees, represented by Planned Parenthood Federation of America (PPFA) filed a claim with the Equal Employment Opportunity Commission, charging that Dow Jones’ health policy discriminated against women by excluding contraceptive coverage. While the company “voluntarily changed” its policy, it denied any wrongdoing, instead citing a desire to avoid litigation. The revised coverage, expected to take effect next month, includes reimbursements to present and former employees for contraceptives and related expenses incurred since January 1, 2001.

According to PPFA, women of reproductive age throughout the US pay more out-of-pocket health care costs than men because of reproductive health expenses not covered by insurance plans. “Contraception is basic health care,” said PPFA President Gloria Feldt. “Studies indicate that most Americans believe prescription contraception should be covered. It’s time for corporations such as Dow Jones to do what is right for the health of America’s women.”

In related news, an article appearing today in the New York Times summarizes the growing options in contraception. With the discontinuation last July of the once-popular contraceptive implant Norplant and recent recalls of the contraceptive injection Lunelle, new products such as the non-surgical sterilization device Essure, the three-week birth control patch Ortho Evra, and the flexible vaginal ring NuvaRing are poised to gain market share.

Media Resources: Kaisernetwork.org 12/6/02; Editor and Publisher Online 12/9/02; NY Times 12/10/02; Feminist Daily News Digest


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

1/27/2016 Study Exposes 'Gender Gap' in Media Coverage of Reproductive Issues - A new study by the Women's Media Center has revealed more than half of news stories focusing on reproductive issues are written by men. According to WMC Media Watch: the Gender Gap in Coverage of Reproductive Issues, men penned 52 percent of bylines discussing issues of reproductive health care - including contraception and abortion - compared to just 37 percent by women. . . .
 
1/27/2016 Taiwan Elects First Woman President - In a landslide victory, the leader of Taiwan's Democratic Progressive Party (DPP) Tsai Ing-wen won the country's presidential election, becoming the first woman in Taiwan's history to hold the position. Emphasizing her party's commitment to maintaining Taiwan's independence from China, Tsai won over young voters eager to usher in a political changing of the guard following some 70 years of dominance by the pro-Chinese unification party, the Kuomintang (KMT), chaired by presidential opponent Eric Chu. . . .
 
1/26/2016 Anti-Abortion Extremists Behind Planned Parenthood Attack Videos Indicted - Two anti-abortion extremists responsible for last year's misleading videos attacking Planned Parenthood have been indicted on criminal charges by a grand jury in Houston, Texas. On Monday, Harris County district attorney Devon Anderson announced that David Daleiden, the director of the Center for Medical Progress (CMP) - the group behind deceptive videos falsely accusing Planned Parenthood of illegally selling fetal tissue - was indicted on a felony charge of tampering with a governmental record and on a misdemeanor charge related to the purchasing of human organs. . . .